|
1
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chou AJ and Gorlick R: Chemotherapy
resistance in osteosarcoma: Current challenges and future
directions. Expert Rev Anticancer Ther. 6:1075–1085. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwartz CL, Gorlick R, Teot L, Krailo M,
Chen Z, Goorin A, Grier HE, Bernstein ML and Meyers P; Children's
Oncology Group: Multiple drug resistance in osteogenic sarcoma:
INT0133 from the Children's Oncology Group. J Clin Oncol.
25:2057–2062. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wafa H and Grimer RJ: Surgical options and
outcomes in bone sarcoma. Expert Rev Anticancer Ther. 6:239–248.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oertel S, Blattmann C, Rieken S, Jensen A,
Combs SE, Huber PE, Bischof M, Kulozik A, Debus J and Schulz-Ertner
D: Radiotherapy in the treatment of primary osteosarcoma - a single
center experience. Tumori. 96:582–588. 2010.PubMed/NCBI
|
|
7
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Picci P, Mercuri M, Ferrari S, Alberghini
M, Briccoli A, Ferrari C, Pignotti E and Bacci G: Survival in
high-grade osteosarcoma: Improvement over 21 years at a single
institution. Ann Oncol. 21:1366–1373. 2010. View Article : Google Scholar
|
|
9
|
Arai K, Sakamoto R, Kubota D and Kondo T:
Proteomic approach toward molecular backgrounds of drug resistance
of osteosarcoma cells in spheroid culture system. Proteomics.
13:2351–2360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Robert RS, Ottaviani G, Huh WW, Palla S
and Jaffe N: Psychosocial and functional outcomes in long-term
survivors of osteosarcoma: A comparison of limb-salvage surgery and
amputation. Pediatr Blood Cancer. 54:990–999. 2010.PubMed/NCBI
|
|
11
|
Shangguan WJ, Li H and Zhang YH: Induction
of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in
human osteosarcoma MG 63 cells through the mitochondrial pathway.
Oncol Rep. 31:3051–313. 2014.
|
|
12
|
Li Z, Yu Y, Sun S, Qi B, Wang W and Yu A:
Niclosamide inhibits the proliferation of human osteosarcoma cell
lines by inducing apoptosis and cell cycle arrest. Oncol Rep.
33:1763–1768. 2015.PubMed/NCBI
|
|
13
|
Wei J, Zhu Y, Xu G, Yang F, Guan Z, Wang M
and Fang Y: Oxymatrine extracted from Sophora flavescens inhibited
cell growth and induced apoptosis in human osteosarcoma MG-63 cells
in vitro. Cell Biochem Biophys. 70:1439–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahmed S, Anuntiyo J, Malemud CJ and Haqqi
TM: Biological basis for the use of botanicals in osteoarthritis
and rheumatoid arthritis: A review. Evid Based Complement Alternat
Med. 2:301–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li PP, He W, Yuan PF, Song SS, Lu JT and
Wei W: Celastrol induces mitochondria-mediated apoptosis in
hepatocellular carcinoma Bel-7402 cells. Am J Chin Med. 43:137–148.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mi C, Shi H, Ma J, Han LZ, Lee JJ and Jin
X: Celastrol induces the apoptosis of breast cancer cells and
inhibits their invasion via downregulation of MMP-9. Oncol Rep.
32:2527–2532. 2014.PubMed/NCBI
|
|
17
|
Ni H, Zhao W, Kong X, Li H and Ouyang J:
NF-kappa B modulation is involved in celastrol induced human
multiple myeloma cell apoptosis. PLoS One. 9:e958462014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao X, Gao S, Ren H, Huang H, Ji W and
Hao J: Inhibition of autophagy strengthens celastrol-induced
apoptosis in human pancreatic cancer in vitro and in vivo models.
Curr Mol Med. 14:555–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee HW, Jang KS, Choi HJ, Jo A, Cheong JH
and Chun KH: Celastrol inhibits gastric cancer growth by induction
of apoptosis and autophagy. BMB Rep. 47:697–702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Song J, Wu D, Wang J and Dong W:
Hesperetin induces the apoptosis of hepatocellular carcinoma cells
via mitochondrial pathway mediated by the increased intracellular
reactive oxygen species, ATP and calcium. Med Oncol. 32:1012015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pieme C, Santosh G, Tekwu E, Askun T,
Aydeniz H, Ngogang J, Bhushan S and Saxena A: Fruits and barks
extracts of Zanthozyllum heitzii a spice from Cameroon induce
mitochondrial dependent apoptosis and G0/G1 phase arrest in human
leukemia HL-60 cells. Biol Res. 47:542014. View Article : Google Scholar
|
|
22
|
Zhang K, Wang X, Wang C, Zheng H, Li T,
Xiao S, Wang M, Fei C, Zhang L and Xue F: Investigation of
quinocetone-induced mitochondrial damage and apoptosis in HepG2
cells and compared with its metabolites. Environ Toxicol Pharmacol.
39:555–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Landriscina M, Laudiero G, Maddalena F,
Amoroso MR, Piscazzi A, Cozzolino F, Monti M, Garbi C, Fersini A,
Pucci P, et al: Mitochondrial chaperone Trap1 and the calcium
binding protein Sorcin interact and protect cells against apoptosis
induced by antiblastic agents. Cancer Res. 70:6577–6586. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Manfredi G, Kwong JQ, Oca-Cossio JA,
Woischnik M, Gajewski CD, Martushova K, D'Aurelio M, Friedlich AL
and Moraes CT: BCL-2 improves oxidative phosphorylation and
modulates adenine nucleotide translocation in mitochondria of cells
harboring mutant mtDNA. J Biol Chem. 278:5639–5645. 2003.
View Article : Google Scholar
|
|
27
|
Chang HY and Yang X: Proteases for cell
suicide: Functions and regulation of caspases. Microbiol Mol Biol
Rev. 64:821–846. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao X, Bennett RL and May WS: c-Myc and
caspase-2 are involved in activating Bax during cytotoxic
drug-induced apoptosis. J Biol Chem. 283:14490–14496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stennicke HR and Salvesen GS: Properties
of the caspases. Biochim Biophys Acta. 1387:17–31. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hui KK, Kanungo AK, Elia AJ and Henderson
JT: Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO
in regulating programmed cell death. Cell Death Differ.
18:1780–1790. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Volkmann N, Marassi FM, Newmeyer DD and
Hanein D: The rheostat in the membrane: BCL-2 family proteins and
apoptosis. Cell Death Differ. 21:206–215. 2014. View Article : Google Scholar :
|
|
32
|
Renault TT and Chipuk JE: Death upon a
kiss: Mitochondrial outer membrane composition and organelle
communication govern sensitivity to BAK/BAX-dependent apoptosis.
Chem Biol. 21:114–123. 2014. View Article : Google Scholar :
|
|
33
|
Westphal D, Kluck RM and Dewson G:
Building blocks of the apoptotic pore: How Bax and Bak are
activated and oligomerize during apoptosis. Cell Death Differ.
21:196–205. 2014. View Article : Google Scholar :
|
|
34
|
Chen PM, Cheng YW, Wu TC, Chen CY and Lee
H: MnSOD overexpression confers cisplatin resistance in lung
adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway. Free Radic Biol
Med. 79:127–137. 2015. View Article : Google Scholar
|
|
35
|
Donskow-Łysoniewska K, Brodaczewska K and
Doligalska M: Heligmosomoides polygyrus antigens inhibit the
intrinsic pathway of apoptosis by overexpression of survivin and
Bcl-2 protein in CD4 T cells. Prion. 7:319–327. 2013. View Article : Google Scholar
|
|
36
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gillies LA and Kuwana T: Apoptosis
regulation at the mitochondrial outer membrane. J Cell Biochem.
115:632–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jourdain A and Martinou JC: Mitochondrial
outer-membrane permeabilization and remodelling in apoptosis. Int J
Biochem Cell Biol. 41:1884–1889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wood WG, Igbavboa U, Muller WE and Eckert
GP: Statins, Bcl-2, and apoptosis: Cell death or cell protection?
Mol Neurobiol. 48:308–314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Villa-Morales M and Fernández-Piqueras J:
Targeting the Fas/FasL signaling pathway in cancer therapy. Expert
Opin Ther Targets. 16:85–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gordon N and Kleinerman ES: Aerosol
therapy for the treatment of osteosarcoma lung metastases:
Targeting the Fas/FasL pathway and rationale for the use of
gemcitabine. J Aerosol Med Pulm Drug Deliv. 23:189–196. 2010.
View Article : Google Scholar : PubMed/NCBI
|
